baicalin has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, L; Wang, X; Zhang, S; Zhang, Y | 1 |
| Ohkoshi, E; Umemura, N | 1 |
2 other study(ies) available for baicalin and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Wnt Signaling Pathway | 2021 |
Induced overexpression of CD44 associated with resistance to apoptosis on DNA damage response in human head and neck squamous cell carcinoma cells.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Damage; Enzyme Inhibitors; Flavonoids; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Immunoblotting; Medicine, Chinese Traditional; Neoplastic Stem Cells; Squamous Cell Carcinoma of Head and Neck | 2017 |